Profilo
Arnim Helmboldt has been Head of Vice President of Sales and Marketing for SynphaBase AG since 2008.
He held several sales and marketing positions at Ciba, Inc. from 1997 to 2008.
Dr. Helmboldt received degrees from the University of Pavia and the Ecole National Supérieure de Chimie de Montpellier and a PhD from the École Normale Supérieure.
Precedenti posizioni note di Arnim Helmboldt
| Società | Posizione | Fine |
|---|---|---|
SynphaBase AG
 SynphaBase AG Miscellaneous Commercial ServicesCommercial Services SynphaBase AG provides contract research and development services to the pharmaceutical and chemical industry. Its products and services include route finding and process development, production of multi-kg up to metric tons, lab scale synthesis and carbohydrates and glycans. The firm’s catalogue includes monosaccharides as building blocks for glycan synthesis with various protecting group patterns and linker systems, disaccharides, oligosaccharides, glycosyl amino acids; core structures and building blocks for carbohydrate-based vaccine. The company was founded by in Arthur Bodenmüller in December 2000 and is headquartered in Pratteln, Switzerland. | Vendite & Marketing | - |
Formazione di Arnim Helmboldt
| University of Pavia | Undergraduate Degree |
| École Normale Supérieure | Doctorate Degree |
| Ecole Nationale Supérieure de Chimie de Montpellier | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
SynphaBase AG
SynphaBase AG Miscellaneous Commercial ServicesCommercial Services SynphaBase AG provides contract research and development services to the pharmaceutical and chemical industry. Its products and services include route finding and process development, production of multi-kg up to metric tons, lab scale synthesis and carbohydrates and glycans. The firm’s catalogue includes monosaccharides as building blocks for glycan synthesis with various protecting group patterns and linker systems, disaccharides, oligosaccharides, glycosyl amino acids; core structures and building blocks for carbohydrate-based vaccine. The company was founded by in Arthur Bodenmüller in December 2000 and is headquartered in Pratteln, Switzerland. | Commercial Services |
- Borsa valori
- Insiders
- Arnim Helmboldt
